(Q38356258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

Retinoic acid as a therapeutic option in Alzheimer's disease: a focus on cholinergic restoration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

Agnieszka Jankowska-Kulawy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Anna Ronowska

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tadeusz Pawełczyk

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

Hanna Bielarczyk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

Andrzej Szutowicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

15 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

239-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

Thiamine deficiency-related brain dysfunction in chronic liver failure

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Alzheimer's disease, metal ions and metal homeostatic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Cognitive impairment and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Nitric oxide signaling in brain function, dysfunction, and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Short-term effects of zinc on acetylcholine metabolism and viability of SN56 cholinergic neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Metals, oxidative stress and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Effects of NGF on acetylcholine, acetyl-CoA metabolism, and viability of differentiated and non-differentiated cholinergic neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

The cholinergic system in aging and neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Intracellular redistribution of acetyl-CoA, the pivotal point in differential susceptibility of cholinergic neurons and glial cells to neurodegenerative signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Magnetic resonance spectroscopy in common dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Effects of zinc on SN56 cholinergic neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Early detection of Alzheimer's disease using PiB and FDG PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

No evidence for role of extracellular choline-acetyltransferase in generation of gamma oscillations in rat hippocampal slices in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

RS-alpha-lipoic acid protects cholinergic cells against sodium nitroprusside and amyloid-beta neurotoxicity through restoration of acetyl-CoA level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

The rhythm of retinoids in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoids as potential targets for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Towards retinoid therapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoids as a perspective in treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin α 1; ADAP1) in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Vitamin A and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Modulation of cholinergic locus expression by glucocorticoids and retinoic acid is cell-type specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Tamibarotene: a candidate retinoid drug for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

MicroRNA-432 contributes to dopamine cocktail and retinoic acid induced differentiation of human neuroblastoma cells by targeting NESTIN and RCOR1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoic acid is detected at relatively high levels in the CNS of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

L3/Lhx8 is a pivotal factor for cholinergic differentiation of murine embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Choline kinase alpha expression during RA-induced neuronal differentiation: role of C/EBPβ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Differentiation of mouse Neuro 2A cells into dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1008456

10.1586/14737175.2015.1008456

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25683350%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference